• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性缺血性心脏病初级保健患者队列中心血管死亡率的决定因素。BARBANZA 缺血性心脏病(BARIHD)研究。

Determinants of cardiovascular mortality in a cohort of primary care patients with chronic ischemic heart disease. BARBANZA Ischemic Heart Disease (BARIHD) study.

机构信息

Cardiology Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.

出版信息

Int J Cardiol. 2013 Jul 31;167(2):442-50. doi: 10.1016/j.ijcard.2012.01.014. Epub 2012 Feb 2.

DOI:10.1016/j.ijcard.2012.01.014
PMID:22305776
Abstract

BACKGROUND

Prognosis of chronic patients with established ischemic heart disease (IHD) is not fully understood. The objective was to determine which factors are related to cardiovascular death and hospitalizations in patients with IHD within a primary care network.

MATERIALS AND METHODS

A cohort study was carried out by 69 primary care providers in Spain in 2007. Participants were followed up for a mean of 2.2 ± 0.3 years. 1095 patients were recruited if they had established (at least 1 year of known disease) IHD (myocardial infarction or and stable or unstable angina). Several hypothesized determinants of cardiovascular mortality were studied, using Cox proportional hazard regression models. Subgroup analysis was also performed for participants without cardiovascular admissions within the last year.

RESULTS

Mean time since first IHD diagnosis was 7.6 ± 6.0 years. Annual all-cause mortality rate was 3.25%, with 44 cardiovascular deaths and 119 cardiovascular admissions. The main prognostic factor for cardiovascular death was previous heart failure (hazard ratio [HR] 4.32, 95% confidence interval [CI] 2.30 to 8.11, p<0.001). Recent cardiovascular admission doubled the risk for death (HR 2.01, CI 1.06 to 3.81, p=0.031). Results showed that use of beta blockers and increased physical activity were the main protective factors. Patients without a recent cardiovascular admission showed previous heart failure as the main significant factor for cardiovascular death.

CONCLUSIONS

Patients with chronic IHD in a primary care setting may need a closer follow-up in the presence of previous conditions such as heart failure. Physical activity and treatment with beta blockers were the factors giving these patients the greatest protection.

摘要

背景

患有明确缺血性心脏病(IHD)的慢性患者的预后尚不完全清楚。本研究的目的是确定在初级保健网络中,哪些因素与 IHD 患者的心血管死亡和住院相关。

材料和方法

2007 年,西班牙的 69 名初级保健医生进行了一项队列研究。参与者的平均随访时间为 2.2±0.3 年。如果患者患有明确的(至少有 1 年已知疾病)IHD(心肌梗死或稳定性或不稳定性心绞痛),则招募 1095 名患者。使用 Cox 比例风险回归模型研究了心血管死亡率的几个假设决定因素。还对过去 1 年内没有心血管入院的参与者进行了亚组分析。

结果

首次 IHD 诊断后的平均时间为 7.6±6.0 年。全因年死亡率为 3.25%,有 44 例心血管死亡和 119 例心血管入院。心血管死亡的主要预后因素是既往心力衰竭(危险比 [HR] 4.32,95%置信区间 [CI] 2.30 至 8.11,p<0.001)。近期心血管入院使死亡风险增加了一倍(HR 2.01,CI 1.06 至 3.81,p=0.031)。结果表明,β受体阻滞剂的使用和体力活动的增加是主要的保护因素。没有近期心血管入院的患者,既往心力衰竭是心血管死亡的主要显著因素。

结论

在初级保健环境中患有慢性 IHD 的患者,如果存在心力衰竭等既往疾病,可能需要更密切的随访。体力活动和β受体阻滞剂治疗是使这些患者得到最大保护的因素。

相似文献

1
Determinants of cardiovascular mortality in a cohort of primary care patients with chronic ischemic heart disease. BARBANZA Ischemic Heart Disease (BARIHD) study.慢性缺血性心脏病初级保健患者队列中心血管死亡率的决定因素。BARBANZA 缺血性心脏病(BARIHD)研究。
Int J Cardiol. 2013 Jul 31;167(2):442-50. doi: 10.1016/j.ijcard.2012.01.014. Epub 2012 Feb 2.
2
The change in the atrial fibrillation type as a prognosis marker in a community study: long-term data from AFBAR (Atrial Fibrillation in the BARbanza) study.社区研究中作为预后标志物的房颤类型变化:来自AFBAR(巴尔班扎地区房颤)研究的长期数据
Int J Cardiol. 2013 Oct 3;168(3):2146-52. doi: 10.1016/j.ijcard.2013.01.261. Epub 2013 Feb 26.
3
Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.意大利日常临床实践中他汀类药物治疗依从性与非致命性缺血性心脏病风险的回顾性数据库分析结果。
Clin Ther. 2010 Feb;32(2):300-10. doi: 10.1016/j.clinthera.2010.02.004.
4
Prognostic impact of atrial fibrillation progression in a community study: AFBAR Study (Atrial Fibrillation in the Barbanza Area Study).社区研究中房颤进展的预后影响:AFBAR 研究(巴兰萨地区房颤研究)。
Int J Cardiol. 2011 Nov 17;153(1):68-73. doi: 10.1016/j.ijcard.2010.08.042. Epub 2010 Sep 16.
5
NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.NSAID 应用与稳定动脉粥样硬化血栓形成疾病门诊患者心血管结局的相关性。
Am J Med. 2014 Jan;127(1):53-60.e1. doi: 10.1016/j.amjmed.2013.08.017. Epub 2013 Nov 23.
6
Improved survival in patients with chronic mild/moderate systolic heart failure followed up in a specialist clinic.在专科门诊随访的慢性轻/中度收缩性心力衰竭患者中生存率提高。
J Cardiovasc Med (Hagerstown). 2013 Jan;14(1):57-65. doi: 10.2459/JCM.0b013e32834ae697.
7
Temporal changes in resting heart rate and deaths from ischemic heart disease.静息心率的时间变化与缺血性心脏病死亡。
JAMA. 2011 Dec 21;306(23):2579-87. doi: 10.1001/jama.2011.1826.
8
Morbidity and mortality among heart failure patients in Galicia, N.W. Spain: the GALICAP Study.西班牙西北部加利西亚地区心力衰竭患者的发病率和死亡率:GALICAP 研究。
Int J Cardiol. 2009 Jul 24;136(1):56-63. doi: 10.1016/j.ijcard.2008.04.025. Epub 2008 Jul 9.
9
Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up.挪威稳定期肾移植患者的心血管疾病:5年随访期间的发病率和死亡率
Clin Transplant. 2004 Oct;18(5):596-604. doi: 10.1111/j.1399-0012.2004.00235.x.
10
Outcome of Chagas cardiomyopathy in comparison to ischemic cardiomyopathy.恰加斯心肌病与缺血性心肌病的结局比较。
Int J Cardiol. 2013 Jul 31;167(2):486-90. doi: 10.1016/j.ijcard.2012.01.033. Epub 2012 Feb 23.

引用本文的文献

1
Designing a theory- and evidence-based tailored eHealth rehabilitation aftercare program in Germany and the Netherlands: study protocol.中德荷三国联合设计基于理论和循证的定制化电子健康康复后护理方案:研究方案
BMC Public Health. 2013 Nov 19;13:1081. doi: 10.1186/1471-2458-13-1081.
2
Long-term follow-up after autologous skeletal myoblast transplantation in ischaemic heart disease.缺血性心脏病自体骨骼肌成肌细胞移植后的长期随访
Interact Cardiovasc Thorac Surg. 2014 Jan;18(1):61-6. doi: 10.1093/icvts/ivt434. Epub 2013 Oct 14.